PH23052A - Monosulfactams - Google Patents

Monosulfactams

Info

Publication number: PH23052A
Authority: PH; Philippines
Prior art keywords: sub; monosulfactams; formulawherein; monocyclic; exhibited
Prior art date: 1986-01-06

Application number

PH34627A

Other languages

English (en)

Inventor

Joseph Edward Sundeen

Original Assignee

Squibb & Sons Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-01-06

Filing date

1986-12-19

Publication date

1989-03-10

1986-12-19 Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc

1989-03-10 Publication of PH23052A publication Critical patent/PH23052A/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Communicable Diseases (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Plural Heterocyclic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Cephalosporin Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Saccharide Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PH34627A 1986-01-06 1986-12-19 Monosulfactams PH23052A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US06/816,475 US4684722A (en)	1986-01-06	1986-01-06	Monosulfactams

Publications (1)

Publication Number	Publication Date
PH23052A true PH23052A (en)	1989-03-10

Family

ID=25220721

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PH34627A PH23052A (en)	1986-01-06	1986-12-19	Monosulfactams

Country Status (21)

Country	Link
US (1)	US4684722A (es)
EP (1)	EP0229012B1 (es)
JP (1)	JPS62158278A (es)
KR (1)	KR900002244B1 (es)
AT (1)	ATE64393T1 (es)
AU (3)	AU602133B2 (es)
CA (1)	CA1308107C (es)
DD (3)	DD256700A5 (es)
DE (1)	DE3770644D1 (es)
DK (1)	DK3087A (es)
ES (1)	ES2038127T3 (es)
FI (1)	FI870030L (es)
GR (1)	GR3002312T3 (es)
HU (2)	HU198700B (es)
IL (1)	IL81153A (es)
NO (1)	NO166860C (es)
NZ (1)	NZ218682A (es)
PH (1)	PH23052A (es)
SU (1)	SU1517762A3 (es)
YU (2)	YU227886A (es)
ZA (1)	ZA8771B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6452767A (en) *	1986-03-19	1989-02-28	Banyu Pharma Co Ltd	2-(2-aminothiazol-4-yl)-2-(1-carboxy-1-vinyloxyimino)acetic acid derivative and production thereof
JPS6393796A (ja) *	1986-10-09	1988-04-25	Shin Etsu Chem Co Ltd	ペプチド合成の脱保護基用薬剤
US5143913A (en) *	1988-04-04	1992-09-01	E. R. Squibb & Sons, Inc.	[3S(Z)]-3-[[(2-amino-4-thiazolyl)[[2-(hydroxyamino)-2-oxoethoxy]imino]acetyl]amino]-2,2-dimethyl-4-oxo-1-azetidinyl sulfate
JPH07165740A (ja) *	1994-11-07	1995-06-27	Banyu Pharmaceut Co Ltd	２−（２−アミノチアゾリル）−２−（１−カルボキシ−１−ビニルオキシイミノ）酢酸及びその製法
US5952306A (en) *	1996-01-16	1999-09-14	Merck & Co., Inc.	Integrin receptor antagonists
EP0880511A4 (en) *	1996-01-16	1999-06-16	Merck & Co Inc	INTEGRIN RECEPTOR ANTAGONISTS
US9120796B2 (en)	2013-10-02	2015-09-01	Cubist Pharmaceuticals, Inc.	B-lactamase inhibitor picoline salt
CN108368040B (zh)	2015-12-15	2024-08-23	默沙东有限责任公司	二芳基单环β-内酰胺化合物及其用于治疗细菌感染的方法
RU2733402C2 (ru)	2016-03-07	2020-10-01	Мерк Шарп И Доум Корп.	Бициклические арильные монобактамовые соединения и способы их применения для лечения бактериальных инфекций
US10002721B1 (en) *	2017-02-27	2018-06-19	Carling Technologies, Inc.	Multiple contact circuit breaker
MX2020003581A (es)	2017-10-02	2020-07-22	Merck Sharp & Dohme	Compuestos monobactamicos cromanos para el tratamiento de infecciones bacterianas.
CN113754651B (zh) *	2020-06-02	2023-04-18	中国医学科学院医药生物技术研究所	一种β-内酰胺化合物、其用途及其制备方法
CN118255695B (zh) *	2024-02-26	2025-03-14	广州艾奇西医药科技有限公司	一种β-内酰胺类化合物的中间体的纯化方法和制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU526540B2 (en) *	1976-04-12	1983-01-20	Fujisawa Pharmaceutical Co., Ltd.	Oximes of substituted phenyl, thiazolyl - glyoxylic acids
DE2716677C2 (de) *	1977-04-15	1985-10-10	Hoechst Ag, 6230 Frankfurt	Cephemderivate und Verfahren zu ihrer Herstellung
GB1602725A (en) *	1977-04-27	1981-11-18	Glaxo Operations Ltd	7-(a-oxyiminoacetamido)-ceph-3-em-4-carboxylic acid derivatives
US4409214A (en) *	1979-11-19	1983-10-11	Fujisawa Pharmaceutical, Co., Ltd.	7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
US4533660A (en) *	1980-10-31	1985-08-06	E. R. Squibb & Sons, Inc.	Antibacterial O-sulfated β-lactam hydroxamic acids
JPS58113174A (ja) *	1981-12-26	1983-07-05	Toyama Chem Co Ltd	新規なアゼチジン誘導体またはその塩類を含有する抗菌剤
US4443374A (en) *	1982-02-01	1984-04-17	E. R. Squibb & Sons, Inc.	Process for preparing (3S)-3-[[(2-amino-4-thiazolyl)[(1-carboxy-1-methylethoxy)imino]-acetyl]amino]-2-oxo-1-azetidinesulfonic acid, and 4-substituted derivatives
AU564150B2 (en) *	1982-04-30	1987-08-06	Takeda Chemical Industries Ltd.	1-sulfo-2-azetidinone derivatives
JPS58206589A (ja) *	1982-05-26	1983-12-01	Yamanouchi Pharmaceut Co Ltd	２−アゼチジノン誘導体
JPS58210060A (ja) *	1982-05-31	1983-12-07	Takeda Chem Ind Ltd	２−オキソアゼチジン誘導体、その製造法および用途
HU189290B (en) *	1982-05-31	1986-06-30	Banyu Pharmaceutical Co Ltd,Jp	Process for preparing new 2-oxo-1-azetidine-sulphonic acid derivatives and pharmaceutically acceptable salts thereof, further pharmaceutical compositions containing such derivatives as active substances
EP0096296B1 (de) *	1982-06-03	1987-07-29	F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft	1-Sulfo-2-oxoazetidinderivate
DE3377061D1 (en) *	1982-06-03	1988-07-21	Hoffmann La Roche	Process for the preparation of 1-sulfo-2-oxoazetidine derivatives
US4704457A (en) *	1982-06-21	1987-11-03	E. R. Squibb & Sons, Inc.	Process for the preparation of (3S)-3-[[[2-(protected amino)-4-thiazolyl]-oxoacetyl]amino]-2-oxo-1-azetidinesulfonic acid and 4-substituted derivatives thereof
GB8413152D0 (en) *	1983-06-03	1984-06-27	Ici Pharma	Cephalosporin derivatives
DE3342929A1 (de) *	1983-11-26	1985-06-05	Bayer Ag, 5090 Leverkusen	Ss-lactamantibiotika, verfahren zu deren herstellung sowie ihre verwendung als arzneimittel

1986
- 1986-01-06 US US06/816,475 patent/US4684722A/en not_active Expired - Fee Related
- 1986-12-08 CA CA000524775A patent/CA1308107C/en not_active Expired - Lifetime
- 1986-12-17 NZ NZ218682A patent/NZ218682A/xx unknown
- 1986-12-19 PH PH34627A patent/PH23052A/en unknown
- 1986-12-19 AU AU66808/86A patent/AU602133B2/en not_active Ceased
- 1986-12-26 JP JP61315973A patent/JPS62158278A/ja active Pending
- 1986-12-30 YU YU02278/86A patent/YU227886A/xx unknown
1987
- 1987-01-04 IL IL81153A patent/IL81153A/xx unknown
- 1987-01-05 NO NO870031A patent/NO166860C/no unknown
- 1987-01-05 FI FI870030A patent/FI870030L/fi not_active Application Discontinuation
- 1987-01-05 DK DK003087A patent/DK3087A/da not_active Application Discontinuation
- 1987-01-05 ES ES198787100056T patent/ES2038127T3/es not_active Expired - Lifetime
- 1987-01-05 HU HU875581A patent/HU198700B/hu not_active IP Right Cessation
- 1987-01-05 AT AT87100056T patent/ATE64393T1/de not_active IP Right Cessation
- 1987-01-05 DD DD87299092A patent/DD256700A5/de unknown
- 1987-01-05 KR KR1019870000006A patent/KR900002244B1/ko not_active IP Right Cessation
- 1987-01-05 HU HU8722A patent/HU198926B/hu not_active IP Right Cessation
- 1987-01-05 EP EP87100056A patent/EP0229012B1/en not_active Expired - Lifetime
- 1987-01-05 SU SU874028791A patent/SU1517762A3/ru active
- 1987-01-05 DE DE8787100056T patent/DE3770644D1/de not_active Expired - Fee Related
- 1987-01-06 ZA ZA8771A patent/ZA8771B/xx unknown
- 1987-07-08 YU YU01278/87A patent/YU127887A/xx unknown
1988
- 1988-01-05 DD DD88312099A patent/DD267039A5/de unknown
- 1988-01-05 DD DD88312098A patent/DD267035A5/de not_active IP Right Cessation
1990
- 1990-07-10 AU AU58851/90A patent/AU617059B2/en not_active Expired - Fee Related
- 1990-07-10 AU AU58850/90A patent/AU5885090A/en not_active Abandoned
1991
- 1991-07-15 GR GR91401016T patent/GR3002312T3/el unknown

Also Published As

Publication number	Publication date
NO870031L (no)	1987-07-07
DD256700A5 (de)	1988-05-18
HU198926B (en)	1989-12-28
FI870030L (fi)	1987-07-07
KR870007164A (ko)	1987-08-17
NO870031D0 (no)	1987-01-05
YU227886A (en)	1988-02-29
CA1308107C (en)	1992-09-29
SU1517762A3 (ru)	1989-10-23
US4684722A (en)	1987-08-04
DK3087D0 (da)	1987-01-05
DK3087A (da)	1987-07-07
AU5885090A (en)	1990-11-15
AU602133B2 (en)	1990-10-04
IL81153A (en)	1991-06-10
KR900002244B1 (ko)	1990-04-07
AU5885190A (en)	1990-10-25
GR3002312T3 (en)	1992-12-30
ATE64393T1 (de)	1991-06-15
IL81153A0 (en)	1987-08-31
NO166860B (no)	1991-06-03
NZ218682A (en)	1990-05-28
ES2038127T3 (es)	1993-07-16
AU617059B2 (en)	1991-11-14
HU198700B (en)	1989-11-28
JPS62158278A (ja)	1987-07-14
DD267035A5 (de)	1989-04-19
HUT44540A (en)	1988-03-28
NO166860C (no)	1991-09-11
ZA8771B (en)	1987-08-26
YU127887A (en)	1988-04-30
HUT48876A (en)	1989-07-28
AU6680886A (en)	1987-07-09
EP0229012B1 (en)	1991-06-12
DE3770644D1 (de)	1991-07-18
EP0229012A1 (en)	1987-07-15
FI870030A0 (fi)	1987-01-05
DD267039A5 (de)	1989-04-19

Publication	Publication Date	Title
CY1748A (en)	1994-06-03	Phenyl carbamates
PH23052A (en)	1989-03-10	Monosulfactams
EP0143081A3 (en)	1987-01-07	Synthesis of fibrinolytic agents by yeast
GB8700354D0 (en)	1987-02-11	Culture of micro-organisms
CA1270247C (en)	1990-06-12	3-ACYLAMINO-2-OXO-1-AZETIDINESULFONIC ACIDS
GR3007423T3 (es)	1993-07-30
CA1271750C (en)	1990-07-17	3-ACYLAMINO-2-OXO-1-AZETIDINESULFONIC ACIDS
GB2137204B (en)	1986-05-29	Improvements in or relating to macrolideantibiotics
SU1271155A1 (ru)	1996-04-20	Способ создания лазерноактивных центров окраски tl°va*99+ в кристаллах kcl-tl
IT214763Z2 (it)	1990-06-18	Struttura per l'aerazione di scantinati.
SU1262908A1 (ru)	1996-03-10	Гидрохлорид 1-(2'-этоксиэтил)-4-фенил-4-пропионилоксипиперидина, обладающий анальгетической активностью
ZA912127B (en)	1992-11-25	Utilization of enzymes
GB8629579D0 (en)	1987-01-21	Stabilisation of yeast enzymes
JO1307B1 (en)	1986-11-30	Portable toilet
GB8331045D0 (en)	1983-12-29	Synthesis of fibrinolytic agents by yeast